Categories
Uncategorised

Denver Mushroom Ballot

On the 7th of May 2019, the people of Denver voted for the decriminalization of adult possession and use of psilocybin mushrooms.

Owning and eating mushrooms in the state of Denver is now assigned the lowest law enforcement priority, prohibiting the city from spending resources on enforcing related penalties.

What does this entail?

While psilocybin mushrooms aren’t strictly speaking legal, the city’s just no longer allowed to spend tax money on prosecution.
No resources – no arrests.

Hence, to persons 21 or older, owning mushrooms in Denver is now safer than it has been for the last 50 years.

Categories
Uncategorised

Upcoming ballot in Denver on the decriminalisation of magic mushrooms

If Kevin Matthew’s initiative succeeds, Denver (Colorado) might become the first US state to decriminalize the possession of small amounts of psilocybin – halting prosecution of people cultivating/owning magic mushrooms for personal use.

Categories
Uncategorised

Activists, entrepreneurs, and doctors in the US and Canada are working to decriminalize psilocybin psychotherapy and calling for a psychedelic revolution.

The story of a PTSD patient with treatment-resistant depression. AND cancer.

How psilocybe can change lives and fates – and even comes recommended by trained psychiatrists…

Categories
Uncategorised

Hopkins researchers recommend reclassifying psilocybin from schedule I to schedule IV

Because of its low potential for abuse and dependence, Hopkins researchers suggest recategorizing Psilocybin from “no known medical potential and high risk of abuse and dependence” (Schedule I) to “low potential for abuse and accepted medical use” (Schedule IV).

On a sidenote, Psilocybin also is lowest in the potential for lethal overdose as there is no known overdose level.

As for the time frame, Matthew W. Johnson, associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine states: “We expect these final clearance trials to take place in the next five years or so.”

Find the whole article on the John Hopkins University website here.

Categories
Uncategorised

Psilocybin therapy for treatment-resistant depression

October 23, 2018

COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression

COMPASS Pathways, a life sciences company determined to develop cures for treatment-resistant depression based on psilocybin now received “Breakthrough Therapy designation” by the Food and Drug Administration – putting them on the Fast Track to have their psilocybin therapy approved.

Categories
Uncategorised

Welcome to the TNMS

We will publish news from all around the world concerning Magic Truffle Microdosing.